康美药业
(600518)
| 流通市值：273.68亿 | | | 总市值：273.81亿 |
| 流通股本：138.22亿 | | | 总股本：138.29亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,180,626,875.64 | 902,625,974.08 | 894,142,348.78 | 977,841,602.98 |
| 交易性金融资产 | 91,402.64 | 80,045.27 | 79,768.5 | 80,964.53 |
| 应收票据及应收账款 | 2,519,001,801.67 | 2,600,056,254.48 | 2,469,459,156.97 | 2,376,089,517.42 |
| 其中：应收票据 | 45,396,096.1 | 43,155,310.98 | 54,036,384.93 | 44,124,091.52 |
| 应收账款 | 2,473,605,705.57 | 2,556,900,943.5 | 2,415,422,772.04 | 2,331,965,425.9 |
| 应收款项融资 | 55,238,978.27 | 32,220,986.97 | 44,936,346.01 | 14,654,666.96 |
| 预付款项 | 87,677,133.58 | 96,544,656.32 | 129,809,295.16 | 175,562,999.48 |
| 其他应收款合计 | 574,344,551.93 | 658,401,207.51 | 659,922,652.91 | 659,162,931.1 |
| 存货 | 2,452,703,655.87 | 2,440,432,694.78 | 2,512,355,484.3 | 2,510,410,246.96 |
| 其他流动资产 | 159,616,923.15 | 170,601,733.93 | 183,336,715.62 | 186,304,972.11 |
| 流动资产合计 | 7,029,301,322.75 | 6,900,963,553.34 | 6,894,041,768.25 | 6,900,107,901.54 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 1,045,560.24 | 1,081,681.93 | 1,111,586.01 | 1,111,586.01 |
| 投资性房地产 | 2,682,870,160.98 | 2,687,036,631.5 | 2,718,493,893.82 | 2,740,868,666.98 |
| 固定资产 | 3,068,634,809.9 | 3,136,522,116.31 | 3,170,992,500.25 | 3,207,783,399.71 |
| 在建工程 | 170,681,750.53 | 171,865,956.83 | 176,255,667.23 | 175,324,324.81 |
| 生产性生物资产 | 366,842.66 | 371,030.42 | 375,218.18 | 379,405.93 |
| 使用权资产 | 93,032,657.78 | 102,120,219.34 | 106,155,484.14 | 116,059,971 |
| 无形资产 | 391,476,344.91 | 400,994,331.39 | 404,857,671.94 | 409,466,623.05 |
| 商誉 | 106,350,551.22 | 106,350,551.22 | 106,350,551.22 | 106,350,551.22 |
| 长期待摊费用 | 49,436,826.61 | 50,264,664.08 | 51,083,872.73 | 55,050,910.61 |
| 递延所得税资产 | 67,526,844.48 | 70,234,521.97 | 71,028,453.72 | 74,361,934.25 |
| 其他非流动资产 | 22,210,835.91 | 16,933,612.28 | 13,093,011.46 | 10,825,040.15 |
| 非流动资产合计 | 6,653,633,185.22 | 6,743,775,317.27 | 6,819,797,910.7 | 6,897,582,413.72 |
| 资产总计 | 13,682,934,507.97 | 13,644,738,870.61 | 13,713,839,678.95 | 13,797,690,315.26 |
| 流动负债: | | | | |
| 短期借款 | 14,839,858.44 | 20,095,785.03 | 33,001,903.3 | 15,827,647.79 |
| 应付票据及应付账款 | 2,608,535,602.99 | 2,485,301,423.79 | 2,505,033,363.34 | 2,545,687,270.01 |
| 其中：应付票据 | 74,694,835.99 | 53,176,542.69 | 75,165,790.39 | 74,052,220.31 |
| 应付账款 | 2,533,840,767 | 2,432,124,881.1 | 2,429,867,572.95 | 2,471,635,049.7 |
| 预收款项 | 60,217,549.57 | 53,023,462.64 | 48,009,825.69 | 51,317,350.49 |
| 合同负债 | 146,866,646.77 | 136,114,204.06 | 140,222,907.67 | 118,816,866.15 |
| 应付职工薪酬 | 58,809,559.17 | 56,961,942.31 | 49,207,451.25 | 66,584,398.2 |
| 应交税费 | 418,707,947.52 | 411,689,366.12 | 414,988,734.23 | 418,038,334.28 |
| 其他应付款合计 | 1,252,239,614.92 | 1,289,909,664.19 | 1,327,930,346.23 | 1,338,449,354.59 |
| 应付股利 | 2,250,000 | 2,250,000 | 2,250,000 | 2,250,000 |
| 一年内到期的非流动负债 | 25,302,411.46 | 27,297,236.08 | 25,734,905.23 | 28,347,177.78 |
| 其他流动负债 | 1,225,891,717.94 | 1,273,082,383.61 | 1,273,928,152.07 | 1,310,499,391.64 |
| 流动负债合计 | 5,811,410,908.78 | 5,753,475,467.83 | 5,818,057,589.01 | 5,893,567,790.93 |
| 非流动负债: | | | | |
| 租赁负债 | 78,445,921.89 | 84,243,095.09 | 87,914,858.32 | 94,951,726.97 |
| 预计负债 | 17,092,873.6 | 17,653,514.34 | 17,791,813.26 | 17,791,813.26 |
| 递延收益 | 530,151,217.7 | 538,414,607.03 | 547,638,995.5 | 555,779,253.03 |
| 递延所得税负债 | 21,150,419.62 | 23,972,549.88 | 24,707,828.29 | 26,849,311.85 |
| 非流动负债合计 | 646,840,432.81 | 664,283,766.34 | 678,053,495.37 | 695,372,105.11 |
| 负债合计 | 6,458,251,341.59 | 6,417,759,234.17 | 6,496,111,084.38 | 6,588,939,896.04 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 13,828,896,690 | 13,863,866,690 | 13,863,866,690 | 13,863,866,690 |
| 资本公积 | 18,474,263,009.57 | 18,782,890,509.57 | 18,782,890,509.57 | 18,782,890,509.57 |
| 减:库存股 | 763,916,500 | 1,107,514,000 | 1,106,944,529.5 | 1,106,944,529.5 |
| 其他综合收益 | -333,915.4 | -294,658.08 | -264,338.17 | -264,338.17 |
| 专项储备 | 1,567,853.73 | 1,500,536.35 | 1,450,808.82 | 1,441,304.2 |
| 盈余公积 | 1,525,575,798.27 | 1,525,575,798.27 | 1,525,575,798.27 | 1,525,575,798.27 |
| 未分配利润 | -25,879,278,666.17 | -25,875,459,585.62 | -25,883,855,192.68 | -25,892,360,975.48 |
| 归属于母公司股东权益合计 | 7,186,774,270 | 7,190,565,290.49 | 7,182,719,746.31 | 7,174,204,458.89 |
| 少数股东权益 | 37,908,896.38 | 36,414,345.95 | 35,008,848.26 | 34,545,960.33 |
| 股东权益合计 | 7,224,683,166.38 | 7,226,979,636.44 | 7,217,728,594.57 | 7,208,750,419.22 |
| 负债和股东权益合计 | 13,682,934,507.97 | 13,644,738,870.61 | 13,713,839,678.95 | 13,797,690,315.26 |
| 公告日期 | 2025-10-31 | 2025-08-30 | 2025-04-30 | 2025-04-19 |
| 审计意见(境内) | | | | 标准无保留意见 |